ANTIBODY INHIBITING ACTIVITY INVOLVED IN CHEMOKINE HVC002

PROBLEM TO BE SOLVED: To provide a therapeutic or diagnostic agent for various inflammatory diseases each involving the infiltration of eosinophils. SOLUTION: There are provided the subject antibody, a monoclonal antibody capable of specifically recognizing HVC002 and inhibiting the activity involve...

Full description

Saved in:
Bibliographic Details
Main Authors HANAI NOBUO, ANAZAWA HIDEJI, FURUYA AKIKO, SHINKAI AKIO, SHOJI EMI
Format Patent
LanguageEnglish
Published 19.06.2001
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a therapeutic or diagnostic agent for various inflammatory diseases each involving the infiltration of eosinophils. SOLUTION: There are provided the subject antibody, a monoclonal antibody capable of specifically recognizing HVC002 and inhibiting the activity involved in chemokine HVC002, and the other objective therapeutic or diagnostic agent containing the above antibody as active ingredient and intended for various inflammatory diseases each involving the infiltration of eosinophils.
Bibliography:Application Number: JP19990347267